nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—NNMT—Methylation Pathways—COMT—attention deficit hyperactivity disorder	0.0506	0.0733	CbGpPWpGaD
Niacin—NNMT—Methylation—COMT—attention deficit hyperactivity disorder	0.0465	0.0674	CbGpPWpGaD
Niacin—QPRT—nervous system—attention deficit hyperactivity disorder	0.0283	0.0913	CbGeAlD
Niacin—QPRT—central nervous system—attention deficit hyperactivity disorder	0.0272	0.0879	CbGeAlD
Niacin—SLC5A8—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.026	0.0376	CbGpPWpGaD
Niacin—QPRT—brain—attention deficit hyperactivity disorder	0.0216	0.0698	CbGeAlD
Niacin—NNMT—cardiovascular system—attention deficit hyperactivity disorder	0.0207	0.0671	CbGeAlD
Niacin—SLC16A3—forebrain—attention deficit hyperactivity disorder	0.0168	0.0542	CbGeAlD
Niacin—NNMT—midbrain—attention deficit hyperactivity disorder	0.0162	0.0524	CbGeAlD
Niacin—SLC16A3—cardiovascular system—attention deficit hyperactivity disorder	0.0142	0.0458	CbGeAlD
Niacin—NNMT—nervous system—attention deficit hyperactivity disorder	0.0133	0.043	CbGeAlD
Niacin—NNMT—central nervous system—attention deficit hyperactivity disorder	0.0128	0.0414	CbGeAlD
Niacin—NNMT—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0405	CbGeAlD
Niacin—HCAR2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0125	0.0181	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0118	0.0171	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0116	0.0168	CbGpPWpGaD
Niacin—NNMT—brain—attention deficit hyperactivity disorder	0.0102	0.0329	CbGeAlD
Niacin—SLC16A3—nervous system—attention deficit hyperactivity disorder	0.0091	0.0294	CbGeAlD
Niacin—SLC16A3—central nervous system—attention deficit hyperactivity disorder	0.00876	0.0283	CbGeAlD
Niacin—SLCO2B1—forebrain—attention deficit hyperactivity disorder	0.00876	0.0283	CbGeAlD
Niacin—SLC16A1—cardiovascular system—attention deficit hyperactivity disorder	0.00861	0.0278	CbGeAlD
Niacin—SLC16A3—cerebellum—attention deficit hyperactivity disorder	0.00856	0.0277	CbGeAlD
Niacin—HCAR2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00837	0.0121	CbGpPWpGaD
Niacin—NNMT—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00817	0.0118	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00794	0.0115	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00756	0.0109	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00737	0.0107	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00722	0.0104	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00719	0.0104	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00717	0.0104	CbGpPWpGaD
Niacin—SLC16A3—brain—attention deficit hyperactivity disorder	0.00695	0.0225	CbGeAlD
Niacin—SLC16A1—midbrain—attention deficit hyperactivity disorder	0.00672	0.0217	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00666	0.00964	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00652	0.00944	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00641	0.00928	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00631	0.00914	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00618	0.00895	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0059	0.00854	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00569	0.00823	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00567	0.00821	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00563	0.00815	CbGpPWpGaD
Niacin—SLC16A1—nervous system—attention deficit hyperactivity disorder	0.00553	0.0179	CbGeAlD
Niacin—HCAR3—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00539	0.00781	CbGpPWpGaD
Niacin—SLC16A1—central nervous system—attention deficit hyperactivity disorder	0.00532	0.0172	CbGeAlD
Niacin—SLC16A1—cerebellum—attention deficit hyperactivity disorder	0.0052	0.0168	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00507	0.00734	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.005	0.00724	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00497	0.0072	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00497	0.00719	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00481	0.00696	CbGpPWpGaD
Niacin—NNMT—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00478	0.00692	CbGpPWpGaD
Niacin—SLCO2B1—nervous system—attention deficit hyperactivity disorder	0.00475	0.0154	CbGeAlD
Niacin—NNMT—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00475	0.00687	CbGpPWpGaD
Niacin—NNMT—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00471	0.00683	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00471	0.00682	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00471	0.00682	CbGpPWpGaD
Niacin—SLCO2B1—central nervous system—attention deficit hyperactivity disorder	0.00458	0.0148	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00452	0.00655	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00447	0.00648	CbGpPWpGaD
Niacin—SLCO2B1—cerebellum—attention deficit hyperactivity disorder	0.00447	0.0145	CbGeAlD
Niacin—HCAR2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0044	0.00637	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00437	0.00633	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00434	0.00629	CbGpPWpGaD
Niacin—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00434	0.00629	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00429	0.00621	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00427	0.00619	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00424	0.00614	CbGpPWpGaD
Niacin—SLC16A1—brain—attention deficit hyperactivity disorder	0.00422	0.0137	CbGeAlD
Niacin—HCAR3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00417	0.00604	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00412	0.00596	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00406	0.00589	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00405	0.00586	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00405	0.00586	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00404	0.00585	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00395	0.00572	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00394	0.0057	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00388	0.00562	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00387	0.0056	CbGpPWpGaD
Niacin—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.00384	0.0124	CbGeAlD
Niacin—HCAR3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00384	0.00556	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00382	0.00553	CbGpPWpGaD
Niacin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00375	0.0121	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00375	0.00542	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00368	0.00532	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00367	0.00532	CbGpPWpGaD
Niacin—SLCO2B1—brain—attention deficit hyperactivity disorder	0.00363	0.0117	CbGeAlD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00356	0.00516	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00356	0.00515	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0035	0.00506	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00348	0.00504	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00345	0.005	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00345	0.00499	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00344	0.00499	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00337	0.00488	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00332	0.0048	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00327	0.00474	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00326	0.00473	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00322	0.00466	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00306	0.00443	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00305	0.00442	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00301	0.00436	CbGpPWpGaD
Niacin—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.00297	0.0096	CbGeAlD
Niacin—QPRT—Disease—STUB1—attention deficit hyperactivity disorder	0.00292	0.00423	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00288	0.00417	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00286	0.00415	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00285	0.00413	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00281	0.00406	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0028	0.00405	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00275	0.00398	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00272	0.00393	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00271	0.00392	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00266	0.00386	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00266	0.00385	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00265	0.00384	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00263	0.00381	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00263	0.00381	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0026	0.00377	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00257	0.00372	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00255	0.00369	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00252	0.00366	CbGpPWpGaD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00249	0.00361	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00249	0.00361	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00247	0.00357	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00245	0.00355	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00242	0.0035	CbGpPWpGaD
Niacin—SLC22A5—brain—attention deficit hyperactivity disorder	0.00241	0.0078	CbGeAlD
Niacin—SLC16A3—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.00341	CbGpPWpGaD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00234	0.00339	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00232	0.00336	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00229	0.00332	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00225	0.00326	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00217	0.00315	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00214	0.00309	CbGpPWpGaD
Niacin—QPRT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0021	0.00304	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00205	0.00297	CbGpPWpGaD
Niacin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00204	0.00659	CbGeAlD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00202	0.00292	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00197	0.00286	CbGpPWpGaD
Niacin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00196	0.00634	CbGeAlD
Niacin—NNMT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00195	0.00283	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00195	0.00282	CbGpPWpGaD
Niacin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00192	0.0062	CbGeAlD
Niacin—HCAR3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00184	0.00267	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00179	0.00259	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00177	0.00256	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00175	0.00254	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00172	0.00248	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0017	0.00246	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0017	0.00246	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00167	0.00243	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00167	0.00242	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00163	0.00236	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00161	0.00233	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00158	0.00229	CbGpPWpGaD
Niacin—CYP2D6—brain—attention deficit hyperactivity disorder	0.00156	0.00503	CbGeAlD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00156	0.00225	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00154	0.00224	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00223	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00153	0.00222	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00151	0.00218	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0015	0.00218	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0015	0.00217	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00149	0.00215	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00148	0.00215	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00148	0.00214	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00146	0.00212	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00146	0.00211	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00145	0.0021	CbGpPWpGaD
Niacin—QPRT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00145	0.0021	CbGpPWpGaD
Niacin—QPRT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00145	0.0021	CbGpPWpGaD
Niacin—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00145	0.0021	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00144	0.00208	CbGpPWpGaD
Niacin—QPRT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00143	0.00207	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00143	0.00207	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00207	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00141	0.00204	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0014	0.00203	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00139	0.00201	CbGpPWpGaD
Niacin—QPRT—Disease—SNAP25—attention deficit hyperactivity disorder	0.00139	0.00201	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00138	0.00201	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00137	0.00198	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00136	0.00197	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00135	0.00195	CbGpPWpGaD
Niacin—NNMT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00135	0.00195	CbGpPWpGaD
Niacin—NNMT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00135	0.00195	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00134	0.00194	CbGpPWpGaD
Niacin—NNMT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00133	0.00192	CbGpPWpGaD
Niacin—QPRT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00133	0.00192	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00132	0.00191	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00131	0.0019	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00188	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00128	0.00185	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00128	0.00185	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00184	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00126	0.00182	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.00179	CbGpPWpGaD
Niacin—NNMT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00123	0.00179	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0012	0.00174	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00119	0.00173	CbGpPWpGaD
Niacin—QPRT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00116	0.00168	CbGpPWpGaD
Niacin—QPRT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.0011	0.0016	CbGpPWpGaD
Niacin—NNMT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00108	0.00156	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00107	0.00154	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00104	0.00151	CbGpPWpGaD
Niacin—NNMT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00149	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.001	0.00145	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000989	0.00143	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00097	0.0014	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000955	0.00138	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000919	0.00133	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000916	0.00133	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000912	0.00132	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000881	0.00128	CbGpPWpGaD
Niacin—QPRT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000879	0.00127	CbGpPWpGaD
Niacin—QPRT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000873	0.00126	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000865	0.00125	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000848	0.00123	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000835	0.00121	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000821	0.00119	CbGpPWpGaD
Niacin—NNMT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000818	0.00118	CbGpPWpGaD
Niacin—NNMT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000812	0.00118	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000807	0.00117	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000804	0.00116	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000797	0.00115	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000779	0.00113	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000765	0.00111	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000756	0.00109	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000743	0.00108	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000704	0.00102	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000668	0.000967	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000659	0.000954	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000659	0.000954	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000656	0.000951	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000648	0.000939	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000609	0.000882	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000603	0.000873	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000541	0.000784	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000527	0.000763	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00052	0.000753	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000516	0.000747	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000502	0.000726	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000493	0.000714	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000466	0.000674	CbGpPWpGaD
Niacin—QPRT—Disease—EP300—attention deficit hyperactivity disorder	0.00045	0.000652	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000422	0.000611	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000399	0.000578	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000396	0.000574	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—attention deficit hyperactivity disorder	0.000377	0.000546	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000356	0.000515	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000356	0.000515	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000351	0.000509	CbGpPWpGaD
Niacin—NNMT—Metabolism—EP300—attention deficit hyperactivity disorder	0.000351	0.000508	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00035	0.000507	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000349	0.000505	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000346	0.000502	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000325	0.000471	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000284	0.000412	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000276	0.000399	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000271	0.000392	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000261	0.000378	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000228	0.00033	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000216	0.000312	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000214	0.00031	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000171	0.000248	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000144	0.000208	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	9.91e-05	0.000144	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.91e-05	0.000144	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	9.75e-05	0.000141	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—attention deficit hyperactivity disorder	9.25e-05	0.000134	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.07e-05	0.000131	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.92e-05	0.000115	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.54e-05	0.000109	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	6.01e-05	8.7e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.96e-05	8.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.58e-05	3.73e-05	CbGpPWpGaD
